Active, Not Recruiting
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
NCT03710603
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Alfred Hospital Melbourne, Australia
- University Hospital Leuven Leuven, Belgium
- University Hospital Ostrava Ostrava, Czechia
- Odense University Hospital Odense, Denmark